Guillaume Echaudemaison - Profile and Investment Details

Investor Profile

Guillaume Echaudemaison is a Venture Capital, Private Equity Firm, Investment Partner, Investor based in France with a diverse investment portfolio that includes companies such as FeetMe, ASTON iTrade Finance, TIBOT Technologies, Intento Design, Animab, Jolimoi, machtfit, Veact, Anaeropharma Science, JobTeaser, Skinjay, Cambrooke Therapeutics, Dermala, Testbirds, Citalid, Siit, Push Doctor, Eligo Bioscience, LARQ, PEP-Therapy, Ervaccine Technologies, Tubulis, MaaT Pharma, TransferGo, Virovet, HARDLOOP, Opencell, Domain TherapeuticsBotfuel, Foodsmart by Zipongo, Citryll, Keen Eye Technologies, Yelloan, MDoloris Medical Systems, DayTwo, MilliDrop, Izicap, TargEDys, Presto Engineering, Pitchy, Federation Bio, CryoCapCell, NovoBind, Clim8, Corwave, LiMM Therapeutics, Siolta Therapeutics, Axial Biotherapeutics, A-Mansia Biotech, Microbiotica, Mailjet, Actronika, ENTEROME, MycoTechnology, fromAtoB, Freetrade, Launchmetrics, BIOMx, Ideel, Indexima, Business Table, Mint Solutions, HomeRez, Vedanta Biosciences, Expensya, IDnow, Studitemps, MedinCell, payleven, Reelevant, Saagie, Chronotruck, Soan, Scipio Bioscience, Galecto, Hepster, String Bio, LNC Therapeutics, MOVE ‘N SEE, wealthpilot, Opencell Software, HorseCom, Il Etait Un Fruit, FIRE1, . Over time, Guillaume Echaudemaison has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Guillaume Echaudemaison is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Health Care, Telecommunications, Accounting, Wellness, Women Founded, Enterprise Software, Immunotherapy, Fundraising, Health Supplements, Transportation, Android, Energy, Life Science, Health Technology, Portfolio Management, Medical Technologies, Sports Tech, Retail, Startups, Information Technology (IT), Business Development, Finance, IoT, Software, Manufacturing, Biotechnology, Networking, Entrepreneurship, Communication Technology, Nutrition, Innovation, Clinical Trials, FinTech, Consumer Software, Sustainable Energy, Hardware, Insurance, Logistics, Utilities, Social Impact, Digital Health, Regulatory Compliance, Hydrogen Technology, Sustainable Fish Farming, Medical, Telecom, SaaS, Six Sigma, Information Technology, B2B, Therapeutics, Health Tech, Media and Entertainment, Machine Learning, Point of Sale (POS), Pharmaceuticals, Recycling may find it worthwhile to explore potential connections with Guillaume Echaudemaison, as their portfolio suggests a familiarity and interest in this area.

Understanding Guillaume Echaudemaison’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.